Clinical Trial

Interpretation Bias as a Mechanism of Treatment Response in OCD

Recruiting
View on ClinicalTrials.gov →
Summary
This study will conduct a randomized controlled trial of Cognitive Bias Modification for Interpretation (CBM-I) as an augmentation to treatment as usual for obsessive compulsive disorder (OCD). CBM-I is a digital intervention designed to directly manipulate interpretation bias through repeated practice on a training task, thereby inducing cognitive changes in a relatively automatic or implicit manner. Specifically, this study will examine the feasibility, acceptability, and clinical outcomes associated with CBM-I. Adults with obsessive compulsive disorder (OCD) will be recruited from a treatment program for this disorder and participants will be randomly assigned to either receive: 1) up to 12 sessions of CBM-I, or or up to 12 sessions of psychoeducation as a control condition.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-01-25; most recent amendment 2026-05-15.
Status change: Not Yet Recruiting → Recruiting 2022-04-07
Trial Details
NCT Number NCT05224414
Lead Sponsor Mclean Hospital
Conditions Obsessive-Compulsive Disorder
Enrollment 106 participants
Start Date 2022-03-30
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-18